Kenneth Suh
Keine laufenden Positionen mehr
Profil
Kenneth Suh was the founder of Willow Biopharma, Inc. (founded in 2015) and KRIM Biopharma, Inc. (founded in 2013), where he held the titles of President & Chief Executive Officer and President, Chief Executive Officer & Director, respectively.
Currently, he is the Chief Executive Officer & Director at Sauvie, Inc. Additionally, he held the position of President at VIVUS, Inc. from 2018 to 2019 and was the Head-Franchise at Novartis Pharma Canada, Inc. from 2012 to 2013.
Mr. Suh received his undergraduate degree from the University of Guelph.
Aktive Positionen von Kenneth Suh
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Kenneth Suh
| Unternehmen | Position | Ende |
|---|---|---|
| VIVUS, INC. | President | 31.10.2019 |
Willow Biopharma, Inc.
 Willow Biopharma, Inc. Medical/Nursing ServicesHealth Services Willow Biopharma, Inc. engages in the development of biopharmaceutical products. It offers medicine to cure cancer, cardiovascular disease, metabolic disorders, digestive disorders, and dermatologic conditions. The company was founded by Kenneth Suh and is headquartered in Markham, Canada. | Chief Executive Officer | 01.08.2018 |
KRIM Biopharma, Inc.
 KRIM Biopharma, Inc. Medical DistributorsDistribution Services KRIM Biopharma, Inc. distributes pharmaceutical products. The Canadian company was founded by Kenneth Suh. | Founder | 01.08.2015 |
| Novartis Pharma Canada, Inc. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Kenneth Suh
| University of Guelph | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Novartis Pharma Canada, Inc. | |
KRIM Biopharma, Inc.
KRIM Biopharma, Inc. Medical DistributorsDistribution Services KRIM Biopharma, Inc. distributes pharmaceutical products. The Canadian company was founded by Kenneth Suh. | Distribution Services |
Willow Biopharma, Inc.
Willow Biopharma, Inc. Medical/Nursing ServicesHealth Services Willow Biopharma, Inc. engages in the development of biopharmaceutical products. It offers medicine to cure cancer, cardiovascular disease, metabolic disorders, digestive disorders, and dermatologic conditions. The company was founded by Kenneth Suh and is headquartered in Markham, Canada. | Health Services |
